NCT04146220View on ClinicalTrials.gov

Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Lupus Nephritis
Interventions
DRUG

Prednisolone

Patients of the low and the high dose groups recieved prednisolone in different dose for initial 4 weeks, then tapered gradually. Both groups received pulse I/V methylprednisolone 500 mg/day daily for initial 3 days and monthly cyclophosphamide infusion 750-1000 mg/m2 body surface area.

Trial Locations (1)

1217

Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT04146220 - Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis | Biotech Hunter | Biotech Hunter